Intraoperative hyperthermic intrathoracic chemotherapy for pleural extension of pseudomyxoma peritonei.
Dang
Anh
A
Department of Anesthesiology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. adang@mdanderson.org
Mansfield
Paul
P
Ilsin
Burak
B
Hightower
Curtis
C
Aravindan
Natarajan
N
Rice
David
D
Riedel
Bernhard
B
D000328:Adult; D000768:Anesthesia, General; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D000069287:Capecitabine; D017024:Chemotherapy, Adjuvant; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D006979:Hyperthermia, Induced; D007432:Intraoperative Period; D008297:Male; D016685:Mitomycin / Q000008:administration & dosage; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D010534:Peritoneal Neoplasms / Q000473:pathology / Q000628:therapy*; D010997:Pleural Neoplasms / Q000188:drug therapy / Q000556:secondary / Q000601:surgery / Q000628:therapy*; D011553:Pseudomyxoma Peritonei / Q000188:drug therapy / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D019616:Thoracic Surgical Procedures
D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D003841:Deoxycytidine; D016685:Mitomycin; D000069287:Capecitabine; D005472:Fluorouracil